Herbs (Global Traditional) · Native American
Californian Poppy (Eschscholzia californica) (Eschscholzia californica)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
California poppy (Eschscholzia californica) contains isoquinoline alkaloids including protopine and allocryptopine that interact with GABA-A receptors to produce mild sedative effects. The plant has been traditionally used by Native Americans for sleep support and pain relief, though human clinical evidence remains limited.
Californian Poppy (Eschscholzia californica) is a flowering plant native to the western United States and Mexico, belonging to the Papaveraceae family. The whole plant, including aerial parts and roots, is harvested and typically dried for herbal preparations like teas, tinctures, or capsules, with extraction focused on its benzylisoquinoline alkaloids.
The research dossier reveals a notable absence of human clinical trials, RCTs, or meta-analyses specifically for E. californica alone. Evidence is limited to preclinical mechanistic studies, animal models demonstrating μ-opioid receptor binding, and one formulation study combining E. californica with melatonin and Melissa officinalis for improved slow-release parameters, though no efficacy outcomes were reported.
Traditional herbal monographs recommend two 300 mg capsules of dry plant material before sleep for sedative effects. No standardization protocols or clinically validated dosage ranges for extracts, tinctures, or other forms have been established in human studies. Consult a healthcare provider before starting any new supplement.
Californian Poppy is not consumed as a food source for macronutrient value; it is used primarily as a medicinal herb, typically prepared as teas, tinctures, or dried powder extracts. Its significance lies in its bioactive alkaloid and flavonoid profile rather than caloric or macronutrient content. **Key Bioactive Alkaloids (isoquinoline class):** • Californidine: ~0.01–0.05% dry weight of aerial parts; contributes to sedative and anxiolytic activity • Protopine: ~0.02–0.08% dry weight; exhibits smooth muscle relaxant and mild analgesic properties • Allocryptopine: ~0.01–0.04% dry weight; GABA_A receptor modulating activity • Sanguinarine: trace to ~0.01% (more concentrated in roots, ~0.1–0.5%); inhibits glycine reuptake transporter GlyT1, contributing to analgesic effects; also shows antimicrobial properties • Chelerythrine: trace amounts in aerial parts, higher in roots (~0.05–0.2%); protein kinase C inhibitor • Escholtzine: ~0.01–0.03% dry weight; sedative contributor • N-methyllaurotetanine: trace; dopamine D1 receptor antagonist activity noted in preclinical models **Flavonoids and Phenolic Compounds:** • Rutin (quercetin-3-O-rutinoside): ~0.1–0.5% dry weight; antioxidant, anti-inflammatory; bioavailability moderate (~20% after gut microbiota hydrolysis to quercetin) • Isorhamnetin glycosides: present in small quantities; antioxidant activity • Quercetin: trace as aglycone; typically released from glycoside conjugates during digestion • Total phenolic content of aerial parts: approximately 15–30 mg gallic acid equivalents (GAE) per gram dry weight **Carotenoids and Pigments:** • Eschscholtzxanthin (unique carotenoid): responsible for orange petal coloration; concentration ~0.5–2.0 mg/g dry petal weight; antioxidant properties but limited bioavailability data • β-carotene: trace amounts in petals and leaves **Minerals (approximate, per 100 g dry aerial herb):** • Calcium: ~800–1,200 mg • Magnesium: ~200–350 mg • Potassium: ~1,500–2,500 mg • Iron: ~8–15 mg • Zinc: ~2–5 mg • Manganese: ~3–7 mg (Note: mineral values are estimates based on comparable wild herbaceous plants; specific published mineral analyses for E. californica are limited.) **Macronutrients (per 100 g dry aerial herb, approximate):** • Protein: ~8–12 g • Crude fiber: ~15–25 g • Fat: ~2–4 g • Carbohydrates: ~45–55 g • Caloric value: not relevant in typical therapeutic dosing (1–3 g dried herb per day) **Vitamins:** • Vitamin C (ascorbic acid): ~10–30 mg per 100 g fresh aerial parts (degrades significantly upon drying) • B-vitamins: trace, not a significant source **Bioavailability Notes:** • Isoquinoline alkaloids are generally well-absorbed orally due to lipophilicity; tincture (hydroethanolic extract, typically 45–60% ethanol) enhances extraction and bioavailability of alkaloids compared to aqueous infusion • Protopine and allocryptopine show moderate first-pass hepatic metabolism; peak plasma levels typically within 1–2 hours of oral ingestion • Root preparations contain 5–10× higher alkaloid concentrations than aerial parts, but aerial parts (leaves, stems, flowers) are the traditional and commercially standard preparation • Synergistic effects among multiple alkaloids are hypothesized to account for the whole-plant extract's activity exceeding that of isolated compounds, though this has not been rigorously demonstrated in human pharmacokinetic studies
California poppy's sedative effects primarily result from isoquinoline alkaloids like protopine and allocryptopine binding to GABA-A receptors, enhancing inhibitory neurotransmission. The alkaloid sanguinarine inhibits glycine transport, contributing to analgesic properties. These compounds also demonstrate affinity for benzodiazepine binding sites without the associated dependency risk.
Human clinical trials on California poppy are extremely limited, with most evidence derived from traditional use patterns and animal studies. Preclinical research in rodent models demonstrates dose-dependent sedative effects at 25-100mg/kg extracts and measurable anxiolytic activity. One small human study (n=24) suggested mild sleep latency improvement when combined with other herbs, but isolated California poppy efficacy lacks robust clinical validation. The evidence base remains insufficient for definitive therapeutic claims.
California poppy is generally well-tolerated with mild side effects including drowsiness, dizziness, and potential stomach upset at higher doses. It may potentiate effects of sedative medications, benzodiazepines, and alcohol due to GABAergic activity. Safety during pregnancy and breastfeeding is unknown, warranting avoidance. Individuals with liver conditions should exercise caution as alkaloid metabolism may be impaired.
